Press Releases
PRESS RELEASE
Results Published from 2-Year Study of 229 Wounds Treated in an NHS Clinic Show Fluorescence...
PRESS RELEASE
Results from 350-Patient FLAAG Trial Show MolecuLight Point-of-Care Imaging Improves Detection...
PRESS RELEASE
MolecuLight Launches i:X® Sterile Surgical Sleeve for Imaging of Bacteria...
PRESS RELEASE
MolecuLight Announces CMS has Assigned an APC Reimbursement Code for its MolecuLight i:X®...
PRESS RELEASE
MolecuLight Announces Industry Partnership and Virtual Exhibit of its MolecuLight i:X®...
PRESS RELEASE
First Published Study to Report In Vitro Detection of Fluorescence from Bacteria in...
Archive
2020
— PRESS RELEASE
New MolecuLight i:X® Upgrade Enables Faster, More Accurate Digital Wound Measurement
— PRESS RELEASESDVOSB Maness Veteran Medical Partners with MolecuLight to Distribute its i:X® Real-Time Fluorescence Wound Imaging Platform to the US Department of Defence (DoD) and Veterans Affairs (VA)
— PRESS RELEASEAmerican Medical Association Issues Category lll CPT Code for Real-time Fluorescence Wound Imaging
— PRESS RELEASEUniversity Hospitals Ahuja Medical Center Physician First in Ohio to Use Wound Care Imaging Device in Clinical Setting
2019
— PRESS RELEASE
MolecuLight Receives FDA 510(k) Clearance for its i:X® Handheld Fluorescence Imaging Device for Wound Management
— PRESS RELEASEAMA Announces Approval for Category lll CPT Code for Real-time Fluorescence Wound Imaging
— PRESS RELEASEClinical Results from the MolecuLight i:X® Fluorescence Imaging System are Featured in Two Clinical Talks and Seven Posters at the SAWC Fall 2019 Annual Conference
— PRESS RELEASEResults from Clinical Studies using MolecuLight i:X® Fluorescence Imaging System Featured Prominently at the Wounds Canada 2019 Annual Conference
— PRESS RELEASEPublished Study Finds 9/10 Chronic Wound Patients Likely to Have Received More Appropriately Triaged Care with Information from the MolecuLight i:X® Imaging Device
— PRESS RELEASEOxford Finance LLC Provides $7.5M USD Term Loan to MolecuLight® Inc. to Support Global Commercial Expansion
— PRESS RELEASEphotonamic GmbH & Co. KG (Germany) Acquires the Oncology Business from MolecuLight® Inc. (Canada)
2018
— PRESS RELEASE
MolecuLight® Inc.’s first-of-its-kind handheld fluorescence imaging device receives FDA De Novo clearance for US wound care market
— NEWSMolecuLight® partners with SerenaGroup for a multi-center clinical trial
— NEWSMolecuLight clinical insights from EWMA 2018
— NEWSNew Publication: Efficacy of an imaging device at identifying the presence of bacteria in wounds at a plastic surgery outpatients clinic
2017
— BLOG
The role of the MolecuLight i:X in potential improvement of current debridement practices
— PRESS RELEASEMolecuLight announces appointment of Anil Amlani as CEO
— BLOGPredicting the presence of pathogenic bacteria in wounds
— BLOGFish skin for human wounds: Iceland’s pioneering treatment
— NEWSNew Publication: Predicting the presence of pathogenic bacteria in wounds
— NEWSRose Raizman receives EWMA e-poster prize
— NEWSImproving antimicrobial stewardship practices with the MolecuLight i:X
— NEWSHow will fluorescence imaging impact wound care?
— NEWSEWMA 2017 update
— NEWSThe use of MolecuLight i:X in managing burns
— NEWSMolecuLight at SAWC Spring 2017
— NEWSMolecuLight i:X featured in the Toronto Star.
— NEWSMolecuLight i:X performs better than Levine method to maximize sampling of treatment-relevant pathogens in chronic wounds.
— BLOGWill the ‘urgent need’ for new drugs be sufficient in the fight against bacteria?
— NEWSThe MolecuLight i:X a novel solution in the ever-increasing battle against antibiotic resistance?
— BLOGAntibiotic resistance continues to be a real issue
2016
— BLOG
